Ironwood Pharmaceuticals (IRWD) Short Interest Ratio & Short Volume → AI's Next Magnificent Seven (From The Oxford Club) (Ad) Free IRWD Stock Alerts $6.35 -0.10 (-1.55%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ironwood Pharmaceuticals Short Interest DataCurrent Short Interest22,480,000 sharesPrevious Short Interest20,080,000 sharesChange Vs. Previous Month+11.95%Dollar Volume Sold Short$147.47 millionShort Interest Ratio5.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares156,530,000 sharesFloat Size154,820,000 sharesShort Percent of Float14.52%Today's Trading Volume1,615,873 sharesAverage Trading Volume2,381,603 sharesToday's Volume Vs. Average68% Short Selling Ironwood Pharmaceuticals ? Sign up to receive the latest short interest report for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIRWD Short Interest Over TimeIRWD Days to Cover Over TimeIRWD Percentage of Float Shorted Over Time Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…Click below for your free report "Top 5 Tech Stocks to Buy in 2024", Ironwood Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202422,480,000 shares $147.47 million +12.0%14.5%5.2 $6.56 4/30/202420,080,000 shares $155.62 million -5.1%13.0%4.5 $7.75 4/15/202421,160,000 shares $164.84 million -3.6%14.0%4.6 $7.79 3/31/202421,950,000 shares $191.18 million +16.9%14.5%4.6 $8.71 3/15/202418,770,000 shares $169.31 million +21.0%12.4%4 $9.02 2/29/202415,510,000 shares $146.26 million -0.6%10.2%3.8 $9.43 Get the Latest News and Ratings for IRWD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202415,600,000 shares $233.84 million +7.9%10.3%5.5 $14.99 1/31/202414,460,000 shares $205.19 million -10.1%9.5%5.4 $14.19 1/15/202416,080,000 shares $195.37 million +2.0%12.8%6.5 $12.15 12/31/202315,760,000 shares $180.29 million -7.3%10.3%7.4 $11.44 12/15/202317,000,000 shares $189.21 million +2.3%11.2%7.8 $11.13 11/30/202316,620,000 shares $164.54 million -3.1%10.9%6.8 $9.90 11/15/202317,150,000 shares $167.38 million -1.4%11.3%6.9 $9.76 10/31/202317,390,000 shares $155.99 million -0.9%11.4%6.7 $8.97 10/15/202317,540,000 shares $164.00 million -0.6%11.5%6.8 $9.35 9/30/202317,640,000 shares $169.87 million +20.3%11.6%7.1 $9.63 9/15/202314,660,000 shares $122.26 million -5.4%9.6%6.1 $8.34 8/31/202315,500,000 shares $136.40 million +3.9%10.2%7.2 $8.80 8/15/202314,920,000 shares $147.11 million -1.8%9.8%7.1 $9.86 7/31/202315,190,000 shares $168.46 million -6.5%10.0%7.3 $11.09 7/15/202316,250,000 shares $168.35 million +13.5%10.7%7.9 $10.36 6/30/202314,320,000 shares $152.36 million -17.9%9.5%6.4 $10.64 6/15/202317,450,000 shares $192.47 million -1.0%11.5%7 $11.03 5/31/202317,620,000 shares $191.71 million +6.4%11.6%7.3 $10.88 5/15/202316,560,000 shares $174.38 million -3.3%10.9%6.7 $10.53 4/30/202317,130,000 shares $178.32 million -14.9%11.3%7.3 $10.41 4/15/202320,130,000 shares $221.23 million +14.1%13.4%8.8 $10.99 3/31/202317,640,000 shares $185.57 million +8.0%11.8%7.6 $10.52 3/15/202316,330,000 shares $170.32 million +1.0%10.9%8.4 $10.43 2/28/202316,170,000 shares $182.24 million +1.4%10.7%8.3 $11.27 2/15/202315,950,000 shares $178.64 million -0.1%10.6%8.4 $11.20 1/31/202315,970,000 shares $183.97 million +0.1%10.7%8.5 $11.52 1/15/202315,950,000 shares $184.86 million -2.6%10.7%8.7 $11.59 12/30/202216,370,000 shares $202.82 million -3.4%10.9%8.8 $12.39 12/15/202216,950,000 shares $204.25 million +2.8%11.4%8.9 $12.05 11/30/202216,490,000 shares $199.69 million -12.3%11.1%8.2 $12.11 11/15/202218,810,000 shares $214.62 million +9.7%12.6%8.9 $11.41 10/31/202217,150,000 shares $187.62 million -1.6%11.4%8.1 $10.94 10/15/202217,420,000 shares $175.77 million +0.2%11.7%7.5 $10.09 9/30/202217,390,000 shares $180.16 million -3.3%11.7%7.5 $10.36No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY 9/15/202217,980,000 shares $196.16 million -1.1%12.1%7.6 $10.91 8/31/202218,170,000 shares $195.51 million -0.4%12.2%6 $10.76 8/15/202218,240,000 shares $217.24 million +0.9%12.3%5.5 $11.91 7/31/202218,080,000 shares $207.02 million +3.3%12.1%5.3 $11.45 7/15/202217,510,000 shares $203.99 million -6.1%11.7%5.4 $11.65 6/30/202218,650,000 shares $215.03 million +32.5%12.5%5.7 $11.53 6/15/202214,080,000 shares $163.05 million -4.1%9.4%4.3 $11.58 5/31/202214,680,000 shares $165.44 million -7.7%9.8%5.6 $11.27 5/15/202215,900,000 shares $184.28 million -2.8%10.6%6.5 $11.59 4/30/202216,350,000 shares $196.20 million -3.3%10.9%6.5 $12.00 4/15/202216,900,000 shares $208.21 million +5.3%10.9%6.6 $12.32 3/31/202216,050,000 shares $201.91 million +6.2%N/A6 $12.58 3/15/202215,110,000 shares $180.26 million +22.3%9.8%5.9 $11.93 2/28/202212,360,000 shares $132.99 million -6.5%8.0%5 $10.76 2/15/202213,220,000 shares $144.10 million -17.6%8.5%5.4 $10.90 1/31/202216,050,000 shares $178.96 million -3.7%10.1%7.1 $11.15 1/15/202216,670,000 shares $195.37 million -2.1%N/A7.5 $11.72 12/31/202117,030,000 shares $198.57 million -7.0%10.7%8.5 $11.66 12/15/202118,320,000 shares $207.93 million -11.3%11.5%8.9 $11.35 11/30/202120,650,000 shares $229.01 million -1.5%12.9%10.2 $11.09 11/15/202120,960,000 shares $255.50 million -7.0%13.1%11.2 $12.19 10/29/202122,540,000 shares $287.84 million +10.4%14.1%12.1 $12.77 10/15/202120,420,000 shares $278.94 million -0.1%12.9%12 $13.66 9/30/202120,430,000 shares $266.82 million +2.0%12.9%11.7 $13.06 9/15/202120,040,000 shares $242.28 million -4.1%12.6%11.1 $12.09 8/31/202120,890,000 shares $273.66 million +0.2%13.2%11.2 $13.10 8/13/202120,850,000 shares $284.39 million +2.3%13.1%11 $13.64 7/30/202120,380,000 shares $270.44 million +4.1%12.8%10.5 $13.27 7/15/202119,570,000 shares $245.99 million -1.9%12.4%10.2 $12.57 6/30/202119,950,000 shares $256.76 million -3.7%12.6%10.7 $12.87 6/15/202120,710,000 shares $231.54 million +11.1%13.1%12.1 $11.18 5/28/202118,640,000 shares $215.66 million -4.3%11.8%10.5 $11.57 5/14/202119,480,000 shares $223.63 million +6.4%N/A9.2 $11.48 4/30/202118,310,000 shares $206.17 million +0.9%N/A8.5 $11.26 4/15/202118,150,000 shares $192.93 million -6.9%N/A8.3 $10.63 3/31/202119,490,000 shares $213.42 million -5.0%12.6%8.8 $10.95 3/15/202120,510,000 shares $231.97 million +14.5%13.2%9.7 $11.31 2/26/202117,910,000 shares $161.91 million -1.4%11.5%9.2 $9.04 2/12/202118,170,000 shares $183.88 million +5.5%11.7%12 $10.12 1/29/202117,230,000 shares $181.86 million -5.7%11.1%10.5 $10.56 1/15/202118,270,000 shares $207.00 million -0.4%11.8%10.9 $11.33 12/31/202018,340,000 shares $211.09 million -7.0%11.9%11.2 $11.51 12/15/202019,720,000 shares $240.49 million -3.6%12.7%9.7 $12.20 11/30/202020,450,000 shares $241.92 million +0.3%13.2%10.1 $11.83 11/15/202020,380,000 shares $237.63 million -7.9%13.2%10 $11.66 10/30/202022,120,000 shares $212.79 million +5.0%14.3%10.9 $9.62 10/15/202021,060,000 shares $206.18 million +2.2%13.7%10.6 $9.79 9/30/202020,600,000 shares $185.30 million -1.0%13.4%10.4 $9.00 9/15/202020,800,000 shares $211.12 million -2.5%13.5%12.6 $10.15 8/31/202021,330,000 shares $215.43 million -13.4%13.8%11.5 $10.10No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY 8/14/202024,620,000 shares $244.97 million +3.8%16.0%11.3 $9.95 7/31/202023,730,000 shares $217.60 million -4.5%15.4%10.6 $9.17 7/15/202024,840,000 shares $253.86 million -6.5%16.2%11.7 $10.22 6/30/202026,560,000 shares $270.38 million +5.7%17.3%12.7 $10.18 6/15/202025,120,000 shares $233.87 million +3.6%16.4%11.6 $9.31 5/29/202024,250,000 shares $236.44 million -3.7%15.8%11.4 $9.75 5/15/202025,170,000 shares $280.02 million +0.6%16.4%12.4 $11.13 4/30/202025,020,000 shares $250.20 million -4.3%16.3%12.6 $10.00 4/15/202026,140,000 shares $261.66 million -3.9%17.0%13.7 $10.01 3/31/202027,200,000 shares $279.62 million -2.9%17.8%13.5 $10.28 3/13/202027,996,800 shares $272.97 million -3.3%18.3%14.6 $9.75 2/28/202028,950,000 shares $277.92 million +0.8%18.9%15.6 $9.60 2/14/202028,710,000 shares $328.73 million +0.1%18.7%16.1 $11.45 1/31/202028,670,000 shares $317.38 million -0.7%18.9%17.3 $11.07 1/15/202028,870,000 shares $351.64 million +0.7%19.0%16.9 $12.18 12/31/201928,670,000 shares $354.65 million +4.8%18.9%17.8 $12.37 IRWD Short Interest - Frequently Asked Questions What is Ironwood Pharmaceuticals' current short interest? Short interest is the volume of Ironwood Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 22,480,000 shares of IRWD short. 14.52% of Ironwood Pharmaceuticals' shares are currently sold short. Learn More on Ironwood Pharmaceuticals' current short interest. What is a good short interest ratio for Ironwood Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IRWD shares currently have a short interest ratio of 5.0. Learn More on Ironwood Pharmaceuticals's short interest ratio. Which institutional investors are shorting Ironwood Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ironwood Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ironwood Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.52% of Ironwood Pharmaceuticals' floating shares are currently sold short. Is Ironwood Pharmaceuticals' short interest increasing or decreasing? Ironwood Pharmaceuticals saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 22,480,000 shares, an increase of 12.0% from the previous total of 20,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ironwood Pharmaceuticals' float size? Ironwood Pharmaceuticals currently has issued a total of 156,530,000 shares. Some of Ironwood Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ironwood Pharmaceuticals currently has a public float of 154,820,000 shares. How does Ironwood Pharmaceuticals' short interest compare to its competitors? 14.52% of Ironwood Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Ironwood Pharmaceuticals: Zentalis Pharmaceuticals, Inc. (26.09%), Cryoport, Inc. (8.54%), IGM Biosciences, Inc. (24.78%), Kura Oncology, Inc. (16.27%), Bausch Health Companies Inc. (5.17%), Alkermes plc (7.65%), Amicus Therapeutics, Inc. (9.76%), Novavax, Inc. (32.26%), Geron Co. (9.09%), Celldex Therapeutics, Inc. (10.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Ironwood Pharmaceuticals stock? Short selling IRWD is an investing strategy that aims to generate trading profit from Ironwood Pharmaceuticals as its price is falling. IRWD shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ironwood Pharmaceuticals? A short squeeze for Ironwood Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IRWD, which in turn drives the price of the stock up even further. How often is Ironwood Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IRWD, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Zentalis Pharmaceuticals Short Interest Cryoport Short Interest IGM Biosciences Short Interest Kura Oncology Short Interest Bausch Health Companies Short Interest Alkermes Short Interest Amicus Therapeutics Short Interest Novavax Short Interest Geron Short Interest Celldex Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IRWD) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.